Log in

Relevant bibliographies by topics / Sexual dysfunction / Journal articles

To see the other types of publications on this topic, follow the link: Sexual dysfunction.

Journal articles on the topic 'Sexual dysfunction'

Author: Grafiati

Published: 4 June 2021

Last updated: 27 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Sexual dysfunction.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kim, Jong-Dai. "Diabetes and Sexual Dysfunction." Journal of Korean Diabetes 24, no. 1 (March 31, 2023): 18–23. http://dx.doi.org/10.4093/jkd.2023.24.1.18.

Full text

Abstract:

Type 2 diabetes can produce various sexual dysfunctions in both men and women. Prevalence of sexual dysfunction is 25~75% in type 2 diabetes, which is three times that of the general population. As hyperglycemia persists, atherosclerosis progresses, and macrovascular and microvascular complications can occur. Autonomic neuropathy and hypogonadism are principal causes of various sexual dysfunctions such as erectile dysfunction, retrograde ejaculation, and premature ejaculation in males and loss of libido, vaginal dryness, anorgasmia, and dyspareunia in females. Although erectile dysfunction is reversible in early stages, it is more difficult to control as diabetes and associated autonomic dysfunction and microvascular complications progress. Sexual dysfunction can decrease quality of life in type 2 diabetes patients and is a marker of vascular dysfunction. Sexual dysfunction has prognostic value for cardiovascular events in type 2 diabetes. This illustrates the importance of sexual function evaluation in type 2 diabetes patients.

APA, Harvard, Vancouver, ISO, and other styles

2

Bargiota, Alexandra, Konstantinos Dimitropoulos, Vassilios Tzortzis, and Georgios Koukoulis. "Sexual dysfunction in diabetic women." HORMONES 10, no. 3 (July 15, 2011): 196–206. http://dx.doi.org/10.14310/horm.2002.1309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cochat Costa Rodrigues, M. C., R. G. Faria, and S. Almeida. "Sexual Dysfunction in Oncology." European Psychiatry 41, S1 (April 2017): S282. http://dx.doi.org/10.1016/j.eurpsy.2017.02.130.

Full text

Abstract:

IntroductionSexual dysfunction is a common consequence of cancer treatment that affects at least half of men and women treated for pelvic tumors and more than one quarter of individuals with other malignancies.Objectives/aimsIdentification of the main sexual dysfunctions related to cancer treatments. Awareness to the importance of addressing sexuality to cancer patients, identifying the main reasons why healthcare providers usually do not.MethodsLiterature review concerning researched articles published in Pubmed/Medline as well as related bibliography.ResultsMost sexual problems are not caused by the cancer itself, but by toxicities of cancer treatment. Damage during cancer treatment to pelvic nerves, blood vessels and organ structures leads to the highest rates of sexual dysfunction. The most common sexual dysfunction in men under cancer treatment is the loss of desire for sex and erectile dysfunction. In women, the most common sexual dysfunctions are vaginal dryness, dyspareunia and loss of sexual desire, usually accompanied by difficulties in both the arousal and orgasm phases. According to literature, there are many cancer patients who would like to be informed and advised by their healthcare providers about the consequences of cancer treatment on their sexual health. Unfortunately, this rarely happens.ConclusionsThis work intends to publicize current existing information on sexual dysfunction in oncology, focusing on the prevalence, etiology and clinical presentation. The authors also intend to promote communication about sexual function and possible sexual dysfunctions resulting from cancer treatments.Disclosure of interestThe authors have not supplied their declaration of competing interest.

APA, Harvard, Vancouver, ISO, and other styles

4

Hatzimouratidis, Konstantinos. "Epidemiology of Male Sexual Dysfunction." American Journal of Men's Health 1, no. 2 (May 14, 2007): 103–25. http://dx.doi.org/10.1177/1557988306298006.

Full text

Abstract:

Male sexual dysfunction includes erectile dysfunction (ED), ejaculation disorders, orgasmic dysfunctions, and disorders of sexual interest/desire. Although current epidemiologic research supports the high prevalence of ED worldwide, incidence data are limited. Furthermore, prevalence data on other male sexual dysfunctions are also limited whereas incidence data are lacking. These epidemiologic data vary widely due to the different definitions used, the method of sampling, and the unknown value of the instruments used to assess sexual dysfunction. Many of the epidemiologic studies are old and associated with poor methodology. Although risk factors for ED are well described, there are almost no data for risk factors in other sexual dysfunctions. The impact of modification of risk factors in sexual dysfunctions is extremely interesting. To provide evidence-based data, there is an urgent need for new, properly designed epidemiological research.

APA, Harvard, Vancouver, ISO, and other styles

5

Nobre, Pedro J., and José Pinto‐Gouveia. "Dysfunctional sexual beliefs as vulnerability factors for sexual dysfunction." Journal of Sex Research 43, no. 1 (February 2006): 68–75. http://dx.doi.org/10.1080/00224490609552300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Dčttore, Davide, Helen Casale, and Antonella Montano. "Fattori cognitivi ed emotivi legati allo sviluppo del Disturbo Maschile dell'Erezione." RIVISTA DI SESSUOLOGIA CLINICA, no. 2 (December 2009): 21–48. http://dx.doi.org/10.3280/rsc2009-002002.

Full text

Abstract:

- The aim of the present research is to investigate the relation between beliefs about sexuality, cognitive factors, emotional factors, and erectile dysfunction. 15 adult males (aged 29-66) with psychogenic erectile dysfunction were compared with 15 adult non-dysfunctional males (aged 29-71) with regard to their beliefs in sexual myths, their expectations, and their emotions during sexual activity. Erectile dysfunction was assessed by SDI (Sexual Dysfunction Interview) and measured by the International Index of Erectile Function (IIEF). Beliefs about sexuality, as well as cognitive and emotional factors of sexual function were measured respectively by Sexual Dysfunctional Beliefs Questionnaire (SDBQ) and Sexual Modes Questionnaire (SMQ). Results show in dysfunctional group an higher level of dysfunctional or irrational beliefs, of negative emotions and automatic thoughts during sexual activity. Beyond this, our data show high correlations between automatic thoughts and sexual functioning, and between worry and sexual functioning These results emphasize the role of cognitive-emotional processes on erectile dysfunction development and maintenance.

APA, Harvard, Vancouver, ISO, and other styles

7

Bawany, Muhammad Adnan, Abdul Aziz Sahito, Falak Naz, Adnan Ali Khahro, Rabail Bohio, Farrukh Bohio, and Syeda Fiza Nasir. "SEXUAL DYSFUNCTION;." Professional Medical Journal 24, no. 06 (June 5, 2017): 888–92. http://dx.doi.org/10.29309/tpmj/2017.24.06.1190.

Full text

Abstract:

Objectives: To determine the frequency of sexual dysfunction in the patientssuffering from chronic liver disease. Period: 1 year from June 2013 to May 2014. Study Design:An observational study. Setting: Asian Institute of Medical Sciences. Methodology: 150 casesof chronic liver disease including patients of both genders at Asian Institute of medical scienceswho had suggestive history and signs /symptoms of sexual dysfunction. Results: Study found51.3% of total patients were suffering with sexual dysfunction. Out of all participating females,52.2% were affected and among the total male patients 51% males were suffering from sexualdysfunction. Hepatitis C virus (HCV) and Hepatitis B virus (HBV) were positive in 76.7% and11.3%, respectively. Conclusion: Sexual dysfunction is a common complication in the patientssuffering from chronic liver disease.

APA, Harvard, Vancouver, ISO, and other styles

8

Lackamp, Jeanne M. "Sexual Dysfunction." Journal of Clinical Psychiatry 71, no. 01 (January 15, 2010): 94. http://dx.doi.org/10.4088/jcp.09bk05447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Davies, Sonia. "Sexual dysfunction." Nursing Standard 23, no. 50 (August 19, 2009): 58. http://dx.doi.org/10.7748/ns2009.08.23.50.58.c7215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Beck, William W. "Sexual Dysfunction." Postgraduate Obstetrics & Gynecology 16, no. 10 (May 1996): 1–5. http://dx.doi.org/10.1097/00256406-199616100-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Bennett, Nelson. "Sexual Dysfunction." Medical Clinics of North America 102, no. 2 (March 2018): 349–60. http://dx.doi.org/10.1016/j.mcna.2017.10.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Wakley, Gill. "Sexual dysfunction." Current Obstetrics & Gynaecology 12, no. 1 (February 2002): 35–40. http://dx.doi.org/10.1054/cuog.2001.0230.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

IsHak, Waguih William, Albert Mikhail, S. Rod Amiri, Laura A. C. Berman, and Monisha Vasa. "Sexual Dysfunction." FOCUS 3, no. 4 (October 2005): 520–25. http://dx.doi.org/10.1176/foc.3.4.520.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Verhulst, Johan M., and Julia R. Heiman. "Sexual dysfunction." Postgraduate Medicine 77, no. 4 (March 1985): 295–303. http://dx.doi.org/10.1080/00325481.1985.11698935.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Lehne, Gregory K. "Sexual Dysfunction." Journal of Nervous and Mental Disease 193, no. 6 (June 2005): 429–30. http://dx.doi.org/10.1097/01.nmd.0000165302.54683.d4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Wakley, Gill. "Sexual dysfunction." Current Obstetrics & Gynaecology 15, no. 1 (February 2005): 38–45. http://dx.doi.org/10.1016/j.curobgyn.2004.09.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Campbell, Scott. "Sexual Dysfunction in Women; Sexual Dysfunction in Men." Sexual and Relationship Therapy 28, no. 4 (November 2013): 434–35. http://dx.doi.org/10.1080/14681994.2013.794932.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Cohen, Seth D., Steven Mandel, and David B. Samadi. "Assessing Sexual Dysfunction, Part 1: Male Sexual Dysfunction." Guides Newsletter 21, no. 2 (March 1, 2016): 3–8. http://dx.doi.org/10.1001/amaguidesnewsletters.2016.marapr01.

Full text

Abstract:

Abstract To properly assess men and women with sexual dysfunction, evaluators should take a biopsychosocial approach that may require consultation with multiple health care professionals from various fields in order to get to the root of the sexual dysfunction; this multidisciplinary methodology offers the best chance of successful treatment. For males, this article focuses on erectile dysfunction (ED) and hypogonadism. The initial evaluation of ED involves a thorough case history, preferably taken from the patient and partner, physical examination, and proper laboratory and diagnostic tests, including an acknowledgment of the subjective complaint. The diagnosis is established on the basis of an individual's report of the consistent inability to attain and maintain an erection sufficient to permit satisfactory sexual intercourse. Initial workups for ED should entail a detailed history that can be obtained from a validated questionnaire such as the International Index of Erectile Function and the Sexual Health Inventory for Men. Hypogonadism is evaluated using the validated Androgen Deficiency in the Aging Male questionnaire and laboratory testing for testosterone deficiency. Treatments logically can begin with the least invasive and then progress to more invasive strategies after appropriate counseling. The last and most important treatment component when caring for men with sexual dysfunction—and, arguably, the least practiced—is close follow-up.

APA, Harvard, Vancouver, ISO, and other styles

19

Cohen, Seth D., Steven Mandel, and David B. Samadi. "Assessing Sexual Dysfunction Part 2: Female Sexual Dysfunction." Guides Newsletter 21, no. 3 (May 1, 2016): 3–8. http://dx.doi.org/10.1001/amaguidesnewsletters.2016.mayjun01.

Full text

Abstract:

Abstract Sexual dysfunction is more common in women (43%) than men (31%), and the evaluating physician must consider the individual's chronological and physiologic age, personal and interpersonal sexual experiences, life events, and relationship issues that may have an effect on female sexual health. The medical history should include focused questions about medical and/or surgical illnesses, use of medications, and urogynecological history. Validated, reliable, standardized questionnaires are useful to identify the presence or absence of various domains of female sexuality such as sexual desire, sexual arousal, orgasm, and/or sexual pain (eg, the Female Sexual Function Index). Serum hormone testing should be dictated by clinical suspicion, and the physician also may assess multiple androgen and estrogen values, as well as pituitary function and levels of thyroid stimulating hormone. Systemic androgens (eg, systemic dehydroepiandrosterone and/or systemic testosterone) may improve mood, energy, stimulation, sensation, arousal, and orgasm in women with sexual health concerns. Combining a biomedical and psychosocial approach to any kind of sexual dysfunction helps to optimize patient outcomes. In the case of hypoactive sexual desire disorder (HSDD), individual or couples-based therapy with a sexual health therapist should be part of the consultation. If the biologic basis of the sexual health concern can be diagnosed by history, physical examination, laboratory testing, and directed imaging studies, then management can be directed to evidence-based management strategies.

APA, Harvard, Vancouver, ISO, and other styles

20

O'Gorman, Ethna C., Ian T. Bownes, and Wallace W. Dinsmore. "Sexual and marital dysfunction and polypartnerism in sexually transmitted diseases (STD) clinic attenders." Irish Journal of Psychological Medicine 7, no. 1 (March 1990): 32–35. http://dx.doi.org/10.1017/s0790966700016980.

Full text

Abstract:

AbstractSexual dysfunctions are common in S.T.D. (Sexually Transmitted Diseases) Clinic attenders. Marital/relationship dysfunctions frequently follow specific sexual dysfunctions such as erectile, impotence and premature ejaculation. In addition concomitant marital therapy has been shown to enhance treatment for sexual dysfunction. Polypartnerism or multiple or serial sexual partners is also a common feature of S.T.D. clinic attenders. To date, no study has fully evaluated the social, psychological and medical determinants of this behaviour.The study examined the relationship between sexual dysfunction, marital difficulties and polypartnerism in 50 heterosexual STD clinic attenders. Thirty-one per cent of the sample had pathological scores on the Golombok-Rust Inventory of Sexual Satisfaction (GRISS). Forty-two per cent of the sample has pathological scores on the Golombok-Rust Inventory of Marital Satisfaction (GRIMS). There was a significant relationship between sexual dysfunction and marital dysfunction. Polypartnerism was also correlated with sexual and relationship dysfunction. It was felt that by offering treatment for specific sexual dysfunctions identified at STD clinics, marital/relationship difficulties could be averted. Subsequently polypartnerism could be reduced. By altering polypartnerism in this way, an important opportunity to influence vector spread of STD, including HIV infection is afforded.

APA, Harvard, Vancouver, ISO, and other styles

21

Tiugan, A. "Sexual Dysfunctions in Anxious Depressive Disorders." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70774-6.

Full text

Abstract:

Background:The ethiopathogenic mechanisms of depression and anxiety overlap at a certain moment on most part of those of the sexual dysfunction. Hypercorticolezemia from the anxious depressive disorders, with direct impact on the hypocampus (reducing the volume), through the two mechanisms (biological and organic) may generate and especially accentuate the dysfunctions in the sexual activity.Objectives:In more than few cases, the anxious depressive disorders are accompanied by sexual dysfunctions, whDuring antidepressant therapy, especially with inhibitors specific for recapturing serotonine, different types of sexual dysfunctions may appear.Methods:In a retrospective examination, out of 420 patients fulfilling the DSM IV R criteria for the anxious and depressive with anxious and depressive disorder, the presence of sexual dysfunction was highlighted in 340 patients (80,9%). In 260 patients (76,47%) the sexual dysfunction was present in the clinical board of anxiety and depression; in 78 patients (30%) the sexual dysfunction accentuated during antidepressant therapy (predominantly with specific inhibitors for recapturing serotonin). In 80 patients (23,53%), the anxious depressive symptomatology was preceded by sexual dysfunctions in various clinical forms. ich accentuate the anxiety and the depression.Conclusions:The presence of sexual dysfunction in an anxious depressive board represents a negative predictive factor in the evolution of the affective disorder, delaying remission. The use of the mood stabilizer, by increasing GABA in the mezocortical circuit and equilibrating the GABA/DOPAMINE, can be beneficial for the improvement of the sexual dysfunction in the anxious depressive disorders.

APA, Harvard, Vancouver, ISO, and other styles

22

Shakya, Dhana Ratna, R. Maskey, P. Karki, and SK Sharma. "Psycho-sexual Disorders in Clinic Diabetes mellitus Patients of a Teaching Hospital of Eastern Nepal." Journal of Diabetes and Endocrinology Association of Nepal 4, no. 2 (December 31, 2020): 19–23. http://dx.doi.org/10.3126/jdean.v4i2.34591.

Full text

Abstract:

Background: Diabetes mellitus, a chronic disease, is frequently associated with sexual dysfunctions. Identification and management of these dysfunctions are important for overall wellbeing of the patient, though usually neglected. We lack data on this regard from Nepal. Objective: To estimate prevalence of psycho-sexual disorders (with emphasis on erectile dysfunction) in the patients with diabetes mellitus visiting ‘Diabetes clinic’ of a tertiary care teaching hospital in eastern Nepal. Method: It is a hospital-clinic based prevalence study. This study analyzed consecutive diabetes mellitus clinic patients’ response to self response questionnaires ‘Arizona Sexual Experience Scale’ (ASEX) for over all sexual dysfunction and ‘5- Item Version of the International Index of Erectile Dysfunction’ (IIEF-5) for erectile dysfunction. ‘Diabetes mellitus’ diagnosis was made based on the ADA guidelines 2010. Results: Among 100 male clinic diabetes patients, majorities were married, above age 50 years and all diagnosed as type 2 diabetes mellitus. Out of total, 48% had sexual dysfunction by the ASEX and many subjects had erectile dysfunction by the IIEF-5. Conclusion: Psychosexual dysfunctions, mainly erectile dysfunction are common among diabetic patients. Hence, assessment should include attention to sexual problems as well during management of diabetes mellitus.

APA, Harvard, Vancouver, ISO, and other styles

23

Mahan, Vanita. "Assessing and Treating Sexual Dysfunction." Journal of the American Psychiatric Nurses Association 9, no. 3 (June 2003): 90–95. http://dx.doi.org/10.1016/s1078-3903(03)00111-3.

Full text

Abstract:

This article seeks to heighten the awareness of nurses about sexual dysfunction. Although dealing with sexual dysfunction issues might be sensitive, nurses can discuss the subject and elicit important information from patients by following simple rules and careful questioning. Classifications of sexual dysfunctions and the causes and treatment for each are described.

APA, Harvard, Vancouver, ISO, and other styles

24

Lais Pereira Zviegicoski Mayer, Kezia. "Prevalencia e associacao entre as disfuncoes sexual e urinaria em mulheres jovens de Guarapuava PR." Revista Brasileira de Fisioterapia Pelvica 3, no. 1 (April 10, 2023): 62–71. http://dx.doi.org/10.62115/rbfp.2023.3(1)62-71.

Full text

Abstract:

Background: Issues such as urinary function, sexual function and female intimate health are still seen as forbidden in today's society, so when talking about the pelvic floor, many women do not know what it is, and the dysfunctions that occur in this structure. Urinary and sexual dysfunctions are prevalent, but studies in young populations are scarce. Aims: To survey the prevalence of sexual dysfunction (SD) and urinary incontinence (UI) in young women. Method: Investigative cross-sectional study through the Google Forms platform, using the questionnaires: FSFI and PRAFAB under descriptive statistics. Results: Participants were 54 women, mean age 24 years, average sexarch 16 years, 81 had UI (42.5% mild, 37% moderate and 1.8% severe) and 57% had SD. When combined, 46.2% of women had both disorders (20.3 mild UI and sexual dysfunction, 24% moderate UI and sexual dysfunction, and 1.8% severe UI and sexual dysfunction). Conclusion: There are associated urinary and sexual dysfunctions in young women.

APA, Harvard, Vancouver, ISO, and other styles

25

Scanavino, Marco de Tubino. "Sexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management." Advances in Urology 2011 (2011): 1–10. http://dx.doi.org/10.1155/2011/854792.

Full text

Abstract:

Sexual dysfunctions in HIV-positive men are associated with an increase in risky sexual behavior and decreased adherence to antiretroviral drug regimens. Because of these important public health issues, we reviewed the literature on the pathophysiology, associated factors and clinical management of sexual dysfunction in HIV-positive men. The goal was to investigate the current research on these issues. Literature searches were performed in June 2011 on PubMed, Web of Science, and PsycInfo databases with the keywords “AIDS” and “sexual dysfunction” and “HIV” and “sexual dysfunction”, resulting in 54 papers. Several researchers have investigated the factors associated with sexual dysfunction in HIV-positive men. The association between sexual dysfunction and antiretroviral drugs, particularly protease inhibitors, has been reported in many studies. The lack of standardized measures in many studies and the varying study designs are the main reasons that explain the controversial results. Despite some important findings, the pathophysiology of sexual dysfunction in the HAART era still not completely understood. Clinical trials of testosterone replacement therapy have shown the treatment to be beneficial to the improvement of sexual dysfunctions related to hypogonadism. However, there are not enough psychological intervention studies to make conclusions regarding the therapeutic effects of psychotherapy.

APA, Harvard, Vancouver, ISO, and other styles

26

Boyle, Mary. "Sexual Dysfunction or Heterosexual Dysfunction?" Feminism & Psychology 3, no. 1 (February 1993): 73–88. http://dx.doi.org/10.1177/0959353593031005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Patterson, Diana G., and Ethna C. O'Gorman. "Sexual Anxiety in Sexual Dysfunction." British Journal of Psychiatry 155, no. 3 (September 1989): 374–78. http://dx.doi.org/10.1192/bjp.155.3.374.

Full text

Abstract:

Sexual anxiety was examined in 98 patients presenting with sexual dysfunction and 68 of their partners at a psychosexual clinic using the SOMA questionnaire. All patients had raised values for heterosexual anxiety. Female partners had raised values while male partners did not. This provides further evidence for the role of heterosexual anxiety in the aetiology and treatment of sexual dysfunction.

APA, Harvard, Vancouver, ISO, and other styles

28

Shahmoradi, Nasrin, Omran Davarinejad, Annette Beatrix Brühl, and Serge Brand. "Effects of Aphrodite (An Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from A Randomized Clinical Trial." Medicina 59, no. 9 (September 14, 2023): 1663. http://dx.doi.org/10.3390/medicina59091663.

Full text

Abstract:

Background and Objectives: Almost by default, people with major depression disorder (MDD) also report sexual health issues. This holds even more true when sexual dysfunctions are SSRI-induced. Herbal compounds may have the power to counterbalance such sexual dysfunctions, though research is still scarce. Therefore, we assessed females with diagnosed MDD treated with a standard SSRI (sertraline) and reporting SSRI-induced sexual dysfunctions, and we asked whether compared to placebo, Aphrodite® (a blend of ginger, saffron, cinnamon, thistle, and Tribulus terrestris) may favorably impact on sexual dysfunctions, and on symptoms of depression, anxiety, and sleep disturbances. Materials and Methods: A total of 41 females (mean age: 35.05 years) with diagnosed MDD, treated with sertraline (a standard SSRI) at therapeutic dosages, and reporting SSRI-induced sexual dysfunction, were randomly assigned either to Aphrodite or to the placebo condition. At baseline and four and eight weeks later (study end), participants completed a series of self-rating questionnaires covering symptoms of sexual dysfunction, depression, anxiety, and sleep complaints. Results: Symptoms of sexual dysfunction, depression, and anxiety decreased over time, but more so in the Aphrodite condition, compared to the placebo condition (significant p-values and large effect sizes). Over time, sleep disturbances decreased irrespective of the study condition. Conclusions: The pattern of results suggests that compared to placebo, Aphrodite appeared to improve symptoms of sexual dysfunction, depression, and anxiety among females with diagnosed MDD and SSRI-induced sexual dysfunction. Further and similar studies should investigate the underlying psychophysiological mechanisms.

APA, Harvard, Vancouver, ISO, and other styles

29

de Moura Carvalho, Jadna. "Disfuncao sexual do desejo feminino e depressao: revisao." Revista Brasileira de Fisioterapia Pelvica 2, no. 1 (March 15, 2022): 67–73. http://dx.doi.org/10.62115/rbfp.2022.2(1)67-73.

Full text

Abstract:

Background: Sexual dysfunction is defined as an inability to achieve one or more of the phases of the healthy sexual response cycle or pain during sexual intercourse, which may be related to psychological or physiological factors. Aims: To verify how depressive symptoms can affect female sexual function and interfere with women’s quality of life. Method: Integrative literature review of PubMed, SciELO and Virtual Health Library (BVS) databases of articles on depression and female sexual dysfunction. Results: There was a high prevalence of female sexual dysfunction associated with suspected depression, and it is important to investigate a greater number of individuals to identify this condition, these women had difficulties in the first three phases of the cycle of sexual response, lubrication, pain and during sexual activity and sexual dissatisfaction. Conclusion: Sexual dysfunction is highly prevalent in depressed women and women with major depressive disorder, also highly prevalent in women with fibromyalgia syndrome related to a high association of sexual dysfunction and depression, and women who use antidepressants may experience difficulties in the response cycle phases sexual.

APA, Harvard, Vancouver, ISO, and other styles

30

KC, Bipin, Leepa Vaidhya, Rajendra Ghimire, Rajan Sharma, and Melina Karki. "Sexual dysfunction in selective serotonin reuptake inhibitors receiving patients attending psychiatric outpatient department at tertiary level hospital in Pokhara: a cross sectional study." Journal of Patan Academy of Health Sciences 11, no. 1 (June 14, 2024): 33–38. http://dx.doi.org/10.3126/jpahs.v11i1.64495.

Full text

Abstract:

Introduction: Sexual dysfunction is common following treatment with selective serotonin reuptake inhibitors (SSRI) and can have a negative impact on treatment adherence. However, few patients spontaneously report these dysfunctions in clinical settings. The aim of this study was to find out the proportion and pattern of sexual dysfunction following treatment with SSRI. Method: A descriptive cross-sectional study was done in a tertiary level hospital among psychiatric patients visiting the outpatient department from 9 Nov 2022 to 8 Nov 2023, after receiving ethical approval from the institutional review committee. Demographic details, psychiatric diagnosis, medication used, and duration of medication used were recorded. The Depression, Anxiety, and Stress-21 Scale was used to assess depression, anxiety and stress and the psychotrophic related sexual dysfunction questionnaire was used to assess sexual dysfunction and its pattern. Result: A total of 87 patients receiving SSRI were included in the study. The proportion of sexual dysfunction among SSRI recipients was found to be 27(31.03%). The proportion of sexual dysfunction was higher in males 19(70.37%). Among those 27 patients, the most common pattern was decreased libido 17(62.96%), and vaginal lubrication 3(11.11%) was the least common pattern of sexual dysfunction. Out of 27 patients with sexual dysfunction 9(33%) spontaneously reported sexual dysfunction. Conclusion: Nearly one-third of recipients of SSRIs have sexual dysfunction, majority of patients may not report sexual dysfunction spontaneously and sexual dysfunction is seen more in paroxetine recipients.

APA, Harvard, Vancouver, ISO, and other styles

31

Turhan, İpek, and Kübra Akcan. "Current Diagnosis and Treatments of Female Sexual Dysfunction." Gevher Nesibe Journal IESDR 7, no. 17 (March 21, 2022): 57–63. http://dx.doi.org/10.46648/gnj.384.

Full text

Abstract:

Sexual health is an important part of health. The definition of sexual health is one of the basic rights of all people, men, women, young and old, which includes being in complete physical and emotional well-being, as in the definition of health. Sexual dysfunctions are problems that occur due to psychophysiological changes in the sexual response cycle and sexual desire. Although sexual dysfunctions vary according to societies, they are frequently seen problems that reduce the quality of life of the individual and force the individual. Although the incidence of sexual dysfunctions is increasing day by day, it is an important health problem that is little known and less intervened by health professionals. Sexuality has been recognized as an important and integral part of nursing by organizations covered by the American Nursing Association (ANA). The North American Nursing Diagnosis Association added the diagnosis of sexual dysfunction to the list of nursing diagnoses in 1980. Sexuality is an issue that is considered taboo in our country as well as in most societies and is ignored by health professionals. Sexual dysfunction in women is affected by many factors, and sexual dysfunction in women causes lack of self-confidence, emotional stress and deterioration in personal relationships. Sexual problems are affected by biological and psychological factors. Therefore, they must be considered together. In this review, the current diagnosis and treatment of sexual dysfunctions in women are discussed.

APA, Harvard, Vancouver, ISO, and other styles

32

Sousa Rodrigues Guedes, Thais, Marcello Barbosa Otoni Gonçalves Guedes, Rebeca de Castro Santana, José Felipe Costa da Silva, Amanda Almeida Gomes Dantas, Mirari Ochandorena-Acha, Marc Terradas-Monllor, Javier Jerez-Roig, and Dyego Leandro Bezerra de Souza. "Sexual Dysfunction in Women with Cancer: A Systematic Review of Longitudinal Studies." International Journal of Environmental Research and Public Health 19, no. 19 (September 21, 2022): 11921. http://dx.doi.org/10.3390/ijerph191911921.

Full text

Abstract:

Background: Several factors affect sexual function, including cancer development and treatment. This study summarized the risk of women with cancer of developing sexual dysfunctions. Methods: This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We searched the EMBASE, PubMed, LILACS, SciELO, CINAHL, Scopus, and Web of Science databases using the descriptors cancer, neoplasms, sexual dysfunction, sexual function, and women. The Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies assessed the quality of studies. Results: Sixteen studies were included in this review. Women with cancer presented sexual dysfunctions in 14 out of 16 included studies. The incidence of sexual dysfunctions ranged from 30% to 80%, while the risk of developing sexual dysfunction increased 2.7- and 3.5-fold in women with cervical and breast cancer, respectively. Conclusion: Different cancer treatments increase the risk of developing sexual dysfunction in women, especially desire, arousal, and orgasm, leading to biopsychosocial changes in the health of this population.

APA, Harvard, Vancouver, ISO, and other styles

33

Kaundal, Asmita, Prachi Renjhen, Rajeshwari Kumari, Ravi P. Jha, Poojan D. Marwaha, Harpreet Kaur, Sushruti Kaushal, Nisha Malik, and Jyoti Gupta. "Female sexual dysfunction—knowledge, attitude, practices, and barriers encountered by medical fraternity across the country: A web-based cross-sectional study." Journal of Family Medicine and Primary Care 13, no. 4 (April 2024): 1284–90. http://dx.doi.org/10.4103/jfmpc.jfmpc_1013_23.

Full text

Abstract:

ABSTRACT Introduction: Sexual dysfunction in women is common yet often remains underdiagnosed due to the lack of adequate training and experience of the doctors to manage female sexual dysfunctions. This study was done to assess the knowledge and attitude of medical professionals toward female sexual dysfunction and the various practices and barriers they encounter while managing women with sexual dysfunction. Materials and Methods: A web-based cross-sectional study was done using the snowball sampling method. A well-structured, self-administered, and pre-validated questionnaire containing 27 items was administered through social media. Data was collected and evaluated to assess their knowledge, practices they follow, and barriers encountered while managing female sexual dysfunction. Results: A total of 513 doctors participated in the study. Out of all, only 11.1% of the doctors were often seeing patients with sexual dysfunction. Loss of desire (44%), painful intercourse (33%), lack of lubrication (18%), and anorgasmia (5%) are common symptoms with which women present. The majority of doctors (78.9%) were comfortable in starting a conversation, over half (52.6%) were confident in making a diagnosis, and 51.3% were confident in providing sexual counseling. Yet, only 11.1% were routinely screening women for sexual dysfunctions, and 33.8% were providing counseling regarding sexual issues. Lack of time (31.6%), lack of adequate training (57.3%), unavailability of effective treatment (11.9%), patient discomfort (60.62%), and patient’s reluctance to seek treatment (15.8%) were the barriers encountered by doctors. When assessed for knowledge, around 30.9% had excellent knowledge (≥75th percentile) about female sexual dysfunction. Conclusion: Sexual dysfunction among women is an important health issue that significantly affects the social, mental, and physical well-being of those suffering from it. Screening for sexual dysfunction should be done routinely in day-to-day clinical practice to improve the overall quality of life of a couple.

APA, Harvard, Vancouver, ISO, and other styles

34

Balon, R. "Diagnosis and Assessment of Female sexual Dysfunction(s)." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70456-0.

Full text

Abstract:

The first challenge in diagnosing female sexual dysfunction(s) originates in our diagnostic system. The traditional model of classifying sexual dysfunction is anchored in the sexual response cycle: desire - arousal - orgasm - resolution. However, as some experts have pointed out, this classification may be problematic in the area of female sexuality. Both the diagnoses of female hypoactive sexual desire disorder (FHSDD) and female arousal disorder (FSAD) probably need to be redefined and refined. Examples include adding the lack of responsive desire to the FHSDD criteria and creating categories of subjective FSAD and genital FSAD.The second challenge in diagnosis female dysfunction is the lack of solid diagnostic instruments, diagnosis-specific laboratory assays and other specific testing. Specific measures of female sexual functioning, such as Female Sexual Functioning Index, Profile of Female Sexual Functioning, Sexual Function Questionnaire, Sexual Desire and Interest Inventory, and Female Sexual Distress Scale were mostly developed as outcome measures. No solid diagnostic instrument for sexual dysfunction exists, not even a version of the Structured Clinical Interview for DSM sexual dysfunctions. The contribution of imaging techniques, such as ultrasonography, magnetic resonance imaging or thermography, to the diagnosis is unclear, and these techniques are far (if ever) from clinical use.Thus, a detailed comprehensive clinical interview combined with physical examination, possibly a gynecological examination, and in some cases laboratory hormonal testing remains the cornerstone of diagnosing and assessing female sexual dysfunctions.

APA, Harvard, Vancouver, ISO, and other styles

35

Delcea, Cristian. "Erectile dysfunction." International Journal of Advanced Studies in Sexology 1, no. 1 (May 10, 2019): 15–22. http://dx.doi.org/10.46388/ijass.2019.12.113.

Full text

Abstract:

Erectile dysfunctionis is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. In most sexual intercourses you have a Marked difficulty in obtaining an erection and / or a marked difficulty in maintaining an erection and / or a marked decrease in stiffness. Worldwide prevalence of erectile dysfunction is occasionally 13%-21% for those 40-80 years old; frequently 2% for those 40-50 years old; significantly 40%-50% for those 60-70 years old; and 8% for those who have stopped penetrating during the first sexual. The erectile dysfunction may emerge from the beginning of the sexual life or begin after a period of relatively normal sexual function.

APA, Harvard, Vancouver, ISO, and other styles

36

Manjula V., Manjula Munivenkatappa, Janardhana Navaneetham, and Mariamma Philip. "Quality of Marital Relationship and Sexual Interaction in Couples With Sexual Dysfunction: An Exploratory Study From India." Journal of Psychosexual Health 3, no. 4 (October 2021): 332–41. http://dx.doi.org/10.1177/26318318211047547.

Full text

Abstract:

Background: Sexual dysfunction and marital intimacy and quality are found to have a reciprocal relationship. Examining this relationship in couples seeking help for sexual dysfunctions in the cultural context of India is worthwhile. Aim: This study aims to explore the nature of sexual functioning, sexual interaction, sexual communication, and marital intimacy and quality in couples with sexual dysfunction. Further, relationship between the above variables is also examined. Methods: A cross-sectional, single-group exploratory design was adopted. A sample of 155 married heterosexual individuals, with a clinical diagnosis of sexual dysfunction in either of the spouses, was included in the study. The tools used included MINI neuropsychiatric interview, Marital Quality Scale, Marital Intimacy Questionnaire, Dyadic Sexual Communication Scale, and Sexual Interaction Inventory. Results: Erectile dysfunction and premature ejaculation in men and hypoactive sexual desire disorder in women were the most common sexual dysfunctions. Majority of the sample were young adults. About 82% of the sample had moderate-to-severe levels of marital distress. Mood disorder was the most common psychiatric disorder reported in the sample. High levels of intimacy problems were seen with no significant gender differences in the overall marital quality or intimacy. Difficulty in the overall sexual interactions was found; however, higher levels of dissatisfaction with the frequency of sex and lower self-acceptance was reported by men compared to women. Significant interrelationships were found between marital quality and intimacy, sexual interaction, and sexual communication. Conclusions: Sexual dysfunctions and marital distress are closely related. Sexual interaction and sexual communication play a significant role in marital quality and intimacy.

APA, Harvard, Vancouver, ISO, and other styles

37

Bhugra, Dinesh, and Gabriele Colombini. "Sexual dysfunction: classification and assessment." Advances in Psychiatric Treatment 19, no. 1 (January 2013): 48–55. http://dx.doi.org/10.1192/apt.bp.112.010884.

Full text

Abstract:

SummarySexual dysfunction is one of the most common psychiatric disorders, but it is often ignored in assessment. It can be primary or secondary (a result of psychiatric disorder or medication). Success rates in managing sexual dysfunction are relatively high, with good response to psychological and medical interventions. In ICD-10 and DSM-IV-TR, sexual dysfunctions are broadly classified on the basis of the stages of sexual activity, from arousal to orgasm. There are major similarities between ICD and DSM in diagnosis and classification of sexual dysfunction, but both systems raise challenges. These include definitions of what is ‘normal’ and how abnormality is defined. In this article, we describe the role of the two systems and possible amendments that might help researchers and clinicians. We also present key principles for the assessment and treatment of people who experience sexual dysfunction. We consider problems that need to be managed in engaging and in the therapeutic alliance.

APA, Harvard, Vancouver, ISO, and other styles

38

Boa, Ros. "Female sexual dysfunction." South African Medical Journal 104, no. 6 (May 14, 2014): 446. http://dx.doi.org/10.7196/samj.8373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ramlachan, P., and M. M. Campbell. "Male sexual dysfunction." South African Medical Journal 104, no. 6 (May 13, 2014): 447. http://dx.doi.org/10.7196/samj.8376.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Lowy, Michael P. "Sexual dysfunction handbook." Medical Journal of Australia 180, no. 8 (April 2004): 416. http://dx.doi.org/10.5694/j.1326-5377.2004.tb05983.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Fourcroy, Jean L. "Female Sexual Dysfunction." Drugs 63, no. 14 (2003): 1445–57. http://dx.doi.org/10.2165/00003495-200363140-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Dadak, C., and M. Bayerle-Eder. "FEMALE SEXUAL DYSFUNCTION." Akušerstvo, ginekologiâ i reprodukciâ 9, no. 4 (2015): 86–88. http://dx.doi.org/10.17749/2070-4968.2015.9.4.086-088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Kershaw, Victoria, and Swati Jha. "Female sexual dysfunction." Obstetrician & Gynaecologist 24, no. 1 (November 11, 2021): 12–23. http://dx.doi.org/10.1111/tog.12778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Stine, Curtis C., and Mary Collins. "Male Sexual Dysfunction." Primary Care: Clinics in Office Practice 16, no. 4 (December 1989): 1031–56. http://dx.doi.org/10.1016/s0095-4543(21)01360-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Kwon, Heon-Young. "Female Sexual Dysfunction." Journal of the Korean Continence Society 1, no. 1 (1997): 29. http://dx.doi.org/10.5213/jkcs.1997.1.1.29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Lightner, Deborah J. "Female Sexual Dysfunction." Mayo Clinic Proceedings 77, no. 7 (July 2002): 698–702. http://dx.doi.org/10.4065/77.7.698.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Poiana, Catalina. "Male Sexual Dysfunction." Acta Endocrinologica (Bucharest) 1, no. 1 (2008): 233. http://dx.doi.org/10.4183/aeb.2008.233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Armstrong, Duncan S. "Female sexual dysfunction." Canadian Medical Association Journal 187, no. 17 (November 16, 2015): 1312.3–1312. http://dx.doi.org/10.1503/cmaj.1150072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Read, Jane. "Female Sexual Dysfunction." International Review of Psychiatry 7, no. 2 (January 1995): 175–82. http://dx.doi.org/10.3109/09540269509028324.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Ramage, Margaret. "Female sexual dysfunction." Psychiatry 3, no. 2 (February 2004): 16–20. http://dx.doi.org/10.1383/psyt.3.2.16.30310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!